Stem cell researcher Amy Wagers from the Joslin Diabetes Center (JDC) at Harvard Medical School (HMS) has issued a retraction notice for a 2010 paper, as well as a statement of concern with the intent to review a second paper from 2008. Shane Mayack, a former postdoc in Wagers’ lab, was the first author on both papers and maintains the validity of the results.
In a notice published online 13 Oct. 2010 in Nature, Wagers and two other authors retracted their January 2010 paper “Systemic signals regulate ageing and rejuvenation of blood stem cell niches.” The paper claimed that the stem cell aging process may be reversible but the notice references “serious concerns” with the data that led to that hypothesis, prompting a retraction. In a statement, Wagers said that she immediately notified Nature, JDC, and HMS upon reviewing the data and has begun working to repeat the experiments.
Although Mayack has not personally commented on the retractions, her lawyer issued a statement saying that although Mayack realizes the data presentation was improperly handled, she believes the underlying research remains conclusive. Accordingly, Mayack did not sign the retraction notice. Further examination is ongoing to determine if the conclusions presented in either paper are still viable.